Organic selenium ameliorates non-alcoholic fatty liver disease through 5-hydroxytryptamine/bile acid enterohepatic circulation in mice

To investigate the effects of organic selenium (L-selenocystine, L-selenomethionine, and L-selenomethylcysteine) on non-alcoholic fatty liver disease (NAFLD), the NAFLD mice model with hepatic steatosis and fibrosis was established via feeding with a Western diet and CCl4 injection. Compared with th...

Full description

Bibliographic Details
Main Authors: Lin Zhang, Jing-Bo Fan, Xin-Wen Zhang, Yu Liu, Wen-Yao Shi, Khemayanto Hidayat, Jia-Ying Xu, Linxi Yuan, Li–Qiang Qin
Format: Article
Language:English
Published: Elsevier 2023-07-01
Series:Journal of Functional Foods
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1756464623001962